Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. The ...

If you are driving a dually truck, you already know that having four tires at the rear can be both a blessing and a curse. However, during winter, laws of physics don't bend for anyone, which is why ...

Stand at attention for an off-kilter sign of this particular kind of dementia. Nearly 7 million Americans have been diagnosed with dementia, which gradually destroys memory, thinking skills, and the ...

Serving 80% of the largest home care networks across North America, Sensi.AI is the new standard in senior care PALO ALTO, CALIFORNIA / ACCESS Newswire / October 9, 2025 / Sensi.AI, the pioneer in ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...

Steve Macfarlane consults for Eisai, Janssen and Eli Lilly, and participated as a researcher in the donanemab study. Eisai manufactures lecanemab, while donanemab is owned by Eli Lilly. Dementia is a ...

Low doses in mice have can clear up proteins associated with Alzheimer’s disease and restore memory. Human trials are the next step. Lithium has long been a standard treatment in bipolar disorder, but ...

Lyndsey Collins-Praino receives funding from the National Health and Medical Council, the Medical Research Future Fund, the Australian Research Council and various philanthropic organisations. In ...

One of the most elusive animal species may disappear, researchers said. Survival of snow leopard populations could be "precarious" in the future due to the way the elusive mountain cats have evolved, ...

For the first time, a United Nations declaration is pledging to address dementia. On Thursday, world leaders at the U.N. General Assembly in New York laid out a new plan for combating mental health ...

The European Union on Thursday approved the highly contentious Alzheimer's medication Kisunla under strict conditions, with the drug's effectiveness hotly debated by the medical community. "The ...

A scientist who studies the microstructures of neurons, called microtubules, wants to expand research in treating dementia, including Alzheimer’s disease, with short bouts of an extremely ...